AMAG Pharmaceuticals ROCE
What is the ROCE of AMAG Pharmaceuticals?
The ROCE of AMAG Pharmaceuticals, Inc. is -35.20%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with roce similar to AMAG Pharmaceuticals
- Regulus Therapeutics Inc has ROCE of -35.40%
- Clover Health Investments Corp has ROCE of -35.37%
- Rosetta Stone has ROCE of -35.37%
- Immutep has ROCE of -35.34%
- Immutep has ROCE of -35.34%
- FT AlphaDEX Canadian Dividend ETF Comm has ROCE of -35.31%
- AMAG Pharmaceuticals has ROCE of -35.20%
- GoldHaven Resources has ROCE of -35.19%
- Armada Metals Ltd has ROCE of -35.18%
- Zedge Inc has ROCE of -35.11%
- Aurinia Pharmaceuticals Inc has ROCE of -35.07%
- Purple Innovation Inc has ROCE of -34.98%
- Arizona Metals has ROCE of -34.96%